491 related articles for article (PubMed ID: 37109772)
1. Pituitary Tumorigenesis-Implications for Management.
Vamvoukaki R; Chrysoulaki M; Betsi G; Xekouki P
Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109772
[TBL] [Abstract][Full Text] [Related]
2. Insights into pituitary tumorigenesis: from Sanger sequencing to next-generation sequencing and beyond.
Shen AJJ; King J; Scott H; Colman P; Yates CJ
Expert Rev Endocrinol Metab; 2019 Nov; 14(6):399-418. PubMed ID: 31793361
[No Abstract] [Full Text] [Related]
3. Familial pituitary tumors.
Alband N; Korbonits M
Handb Clin Neurol; 2014; 124():339-60. PubMed ID: 25248598
[TBL] [Abstract][Full Text] [Related]
4. The Spectrum of Familial Pituitary Neuroendocrine Tumors.
Armeni E; Grossman A
Endocr Pathol; 2023 Mar; 34(1):57-78. PubMed ID: 36401106
[TBL] [Abstract][Full Text] [Related]
5. Update on the Genetics of Pituitary Tumors.
Barry S; Korbonits M
Endocrinol Metab Clin North Am; 2020 Sep; 49(3):433-452. PubMed ID: 32741481
[TBL] [Abstract][Full Text] [Related]
6. Genetic Aspects of Pituitary Adenomas.
Marques P; Korbonits M
Endocrinol Metab Clin North Am; 2017 Jun; 46(2):335-374. PubMed ID: 28476226
[TBL] [Abstract][Full Text] [Related]
7. Genetic factors in the development of pituitary adenomas.
Vandeva S; Tichomirowa MA; Zacharieva S; Daly AF; Beckers A
Endocr Dev; 2010; 17():121-133. PubMed ID: 19955762
[TBL] [Abstract][Full Text] [Related]
8. Germline and mosaic mutations causing pituitary tumours: genetic and molecular aspects.
Pepe S; Korbonits M; Iacovazzo D
J Endocrinol; 2019 Feb; 240(2):R21-R45. PubMed ID: 30530903
[TBL] [Abstract][Full Text] [Related]
9. The pathophysiology of pituitary adenomas.
Dworakowska D; Grossman AB
Best Pract Res Clin Endocrinol Metab; 2009 Oct; 23(5):525-41. PubMed ID: 19945021
[TBL] [Abstract][Full Text] [Related]
10. Molecular genetic advances in pituitary tumor development.
Yates CJ; Lines KE; Thakker RV
Expert Rev Endocrinol Metab; 2015 Jan; 10(1):35-53. PubMed ID: 30289047
[TBL] [Abstract][Full Text] [Related]
11. Molecular genetics of the cAMP-dependent protein kinase pathway and of sporadic pituitary tumorigenesis.
Boikos SA; Stratakis CA
Hum Mol Genet; 2007 Apr; 16 Spec No 1():R80-7. PubMed ID: 17613552
[TBL] [Abstract][Full Text] [Related]
12. Novel Genetic Causes of Pituitary Adenomas.
Caimari F; Korbonits M
Clin Cancer Res; 2016 Oct; 22(20):5030-5042. PubMed ID: 27742789
[TBL] [Abstract][Full Text] [Related]
13. Familial pituitary adenomas.
Vandeva S; Vasilev V; Vroonen L; Naves L; Jaffrain-Rea ML; Daly AF; Zacharieva S; Beckers A
Ann Endocrinol (Paris); 2010 Dec; 71(6):479-85. PubMed ID: 20961530
[TBL] [Abstract][Full Text] [Related]
14. Somatic and germline mutations in the pathogenesis of pituitary adenomas.
Vandeva S; Daly AF; Petrossians P; Zacharieva S; Beckers A
Eur J Endocrinol; 2019 Dec; 181(6):R235-R254. PubMed ID: 31658440
[TBL] [Abstract][Full Text] [Related]
15. Clinical and Molecular Update on Genetic Causes of Pituitary Adenomas.
Vasilev V; Daly AF; Zacharieva S; Beckers A
Horm Metab Res; 2020 Aug; 52(8):553-561. PubMed ID: 32299111
[TBL] [Abstract][Full Text] [Related]
16. Cyclin-dependent kinase inhibitor 1B (CDKN1B) gene variants in AIP mutation-negative familial isolated pituitary adenoma kindreds.
Tichomirowa MA; Lee M; Barlier A; Daly AF; Marinoni I; Jaffrain-Rea ML; Naves LA; Rodien P; Rohmer V; Faucz FR; Caron P; Estour B; Lecomte P; Borson-Chazot F; Penfornis A; Yaneva M; Guitelman M; Castermans E; Verhaege C; Wémeau JL; Tabarin A; Fajardo Montañana C; Delemer B; Kerlan V; Sadoul JL; Cortet Rudelli C; Archambeaud F; Zacharieva S; Theodoropoulou M; Brue T; Enjalbert A; Bours V; Pellegata NS; Beckers A
Endocr Relat Cancer; 2012 Jun; 19(3):233-41. PubMed ID: 22291433
[TBL] [Abstract][Full Text] [Related]
17. Screening for genetic causes of growth hormone hypersecretion.
Rostomyan L; Beckers A
Growth Horm IGF Res; 2016; 30-31():52-57. PubMed ID: 27756606
[TBL] [Abstract][Full Text] [Related]
18. MEN1, MEN4, and Carney Complex: Pathology and Molecular Genetics.
Schernthaner-Reiter MH; Trivellin G; Stratakis CA
Neuroendocrinology; 2016; 103(1):18-31. PubMed ID: 25592387
[TBL] [Abstract][Full Text] [Related]
19. Consider the context: Ras/ERK and PI3K/AKT/mTOR signaling outcomes are pituitary cell type-specific.
Roof AK; Gutierrez-Hartmann A
Mol Cell Endocrinol; 2018 Mar; 463():87-96. PubMed ID: 28445712
[TBL] [Abstract][Full Text] [Related]
20. Genetics of Acromegaly and Gigantism.
Bogusławska A; Korbonits M
J Clin Med; 2021 Mar; 10(7):. PubMed ID: 33805450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
